Prevalence of BK Viremia in Simultaneous Liver-Kidney Transplant
Enrolling by invitation
Conditions studied: Polyomavirus Infections, BK Viremia, Liver Transplant Infection, Kidney Transplant Infection
In brief
The human BK polyomavirus is a significant risk factor for renal transplant dysfunction and allograft loss. The prevalence of BK viremia (BKV) following kidney transplantation is estimated to be 10-20%.
Key facts
- Study ID
- NCT05224583
- Run by
- Methodist Health System
- People needed
- 50
- Starts
- 2021-11-17
- Expected to finish
- 2028-11-17
- Last updated by the study team
- 2026-03-20
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18 years or older
- SLK recipients transplanted at MDMC between 2015-2020
You may not qualify if…
- Below 18 years of age
- Patients who did not undergo SLK transplant at MDMC
Where it is running
- Methodist Dallas Medical Center — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.